extended take-home guidelines, and the significant benefits such Take-home methadone dose (for up to 27 days in addition to the in-person
In response to COVID-19, the DEA and SAMHSA adopted policies to allow OTPs to increase methadone take-home dosing up to 28 days for Partial agonist: Generates.
In response to COVID-19, the DEA and SAMHSA adopted policies to allow OTPs to increase methadone take-home dosing up to 28 days for Brand names: Subutex.
The legislation will expand universal In response to COVID-19, the DEA and SAMHSA adopted policies to allow OTPs to increase methadone take-home dosing up to
The Substance Abuse and Mental Health Services Administration (SAMHSA) is extending the methadone take-home flexibilities for one year, effective upon the eventual expiration of the COVID-19 Public Health Emergency. This exemption is a continuation of the take-home medication flexibilities that SAMHSA put in place in March 2024 and is in keeping with the newly announced Health and Human
SAMHSA published a Methadone Take-Home Flexibilities Extension Guidance in November 2024. Am J Drug Alcohol Abuse. 20:1-8. doi: 10.1080/ .2024.
Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs. Methadone Take-Home Dosing Guidelines on Use of Illicit Opioids.
Flexibility of Methadone Medication Take-Home Doses in OTPs. In March 2024, due to the COVID-19 Pandemic, SAMHSA issued exemptions allowing OTPs to dispense up to 28 days of take-home methadone doses for stable patients being treated for OUD and up to 14 doses of take-home methadone for less stable patients.
The Substance Abuse and Mental Health Services Administration (SAMHSA) is extending the methadone take-home flexibilities for one year, effective upon the eventual expiration of the COVID-19 Public Health Emergency. This exemption is a continuation of the take-home medication flexibilities that SAMHSA put in place in March 2024 and is in keeping with the newly announced Health and Human
Comments